JNCE - Jounce Therapeutics Inc. (JNCE) CEO Rich Murray on Q4 2020 Results - Earnings Call Transcript

Jounce Therapeutics, Inc. (JNCE) Q4 2020 Earnings Conference Call February 25, 2021 08:00 ET Company Participants Malin Deon - Investor Relations Rich Murray - President & Chief Executive Officer Elizabeth Trehu - Chief Medical Officer Kim Drapkin - Chief Financial Officer Conference Call Participants Boris Peaker - Cowen Mike Ulz - Baird Steve Seedhouse - Raymond James Zegbeh Jallah - ROTH Capital Markets Presentation Operator Good morning, ladies and gentlemen, and welcome to the Jounce Therapeutics Fourth Quarter and Full Year 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. As a reminder, this conference is being recorded at the company's request. I will now turn the call over to your host, Malin Deon with Jounce Therapeutics. Please go ahead. Malin Deon Thank you, operator. Good morning and welcome to the

For further details see:

Jounce Therapeutics, Inc. (JNCE) CEO Rich Murray on Q4 2020 Results - Earnings Call Transcript